New research shows that during natural menstrual cycles, women with asthma who were not taking oral contraceptives (OC) had lower exhaled nitric oxide levels (eNO), a marker of airway inflammation associated with asthma, than women who were taking OC. Researchers from McMaster University in Hamilton, ON, Canada, studied 17 women with asthma [...]
No Comments »
Filed under: Women's Health
WASHINGTON (MedPage Today) — The House of Representatives is just a day away from taking a crucial vote on whether to pass its healthcare reform bill, and key players are standing up and choosing sides.
No Comments »
Filed under: General Health News
Patients in 84% of the nation’s Medicaid programs have access to tobacco-dependence treatment, but the availability and extent of coverage varied significantly, researchers found.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA has approved romidepsin (Istodax) for patients with cutaneous T-cell lymphoma who have received at least one prior systemic therapy.
No Comments »
Filed under: Pharmacy News
Graceway Pharmaceuticals, LLC, a portfolio company of GTCR Golder Rauner, LLC, today announced that the company has acquired from Gilead Sciences, Inc. the worldwide license, including related regulatory filings and intellectual properties, to Gilead’s investigational molecule, GS 9191, for topical use. GS 9191 is an anti-proliferative agent that works by inhibiting cellular DNA synthesis, leading [...]
No Comments »
Filed under: Pharmacy News
GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced its third quarter 2009 financial results and provided an operational update.
No Comments »
Filed under: Pharmacy News
ZIOPHARM Oncology, Inc. presented today at the 15th Annual Connective Tissue Oncology Society (CTOS) Meeting, positive interim data from the multicenter randomized Phase II trial of palifosfamide (ZymafosTM, ZIO-201) treating patients with unresectable or metastatic soft tissue sarcoma.
No Comments »
Filed under: Pharmacy News
Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance, announces today that its most advanced oral antibacterial NXL103 (flopristin/linopristin), has started a Phase II clinical trial in adults with acute bacterial skin and skin structure infections (ABSSSI). The trial is [...]
No Comments »
Filed under: Pharmacy News
Helix BioPharma Corp. announced today that its Phase II trial of Topical Interferon Alpha-2b for the treatment of ano-genital warts (AGW) has completed patient enrollment, with the required 120th patient randomized to enter the trial.
No Comments »
Filed under: Pharmacy News
Amgen today announced that the Phase 3 PRIME “203″ trial evaluating Vectibix® (panitumumab) administered in combination with FOLFOX (an oxaliplatin-based chemotherapy) as a first-line treatment of metastatic colorectal cancer (mCRC) failed to meet a secondary endpoint of overall survival.
No Comments »
Filed under: Pharmacy News
